MedPath

Efficacy Testing of Hibiscus Sabdariffa Extract and Collagen Products

Not Applicable
Completed
Conditions
Skin Condition
Interventions
Dietary Supplement: Placebo sachet
Dietary Supplement: Hibiscus sabdariffa extract and collagen products
Registration Number
NCT05988554
Lead Sponsor
TCI Co., Ltd.
Brief Summary

To assess Hibiscus sabdariffa extract and collagen products on skin condition improvement

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Healthy adults aged above 20 years old
Exclusion Criteria
  • Subject who is not willing to participate in this study.
  • Patients with diseases of the skin, liver, kidney.
  • Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder.
  • Female who is pregnant or nursing or planning to become pregnant during the course of the study.
  • Received facial laser therapy, chemical peeling or UV overexposure (> 3 hr/week) in the past 4 weeks.
  • Constant drug use
  • Students who are currently taking courses taught by the principal investigator of this trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo sachetPlacebo sachet-
Hibiscus sabdariffa extract and collagen productsHibiscus sabdariffa extract and collagen products-
Primary Outcome Measures
NameTimeMethod
The change of skin wrinklesWeek 0, week 4, week 8

VISIA Complexion Analysis System was utilized to measure skin wrinkles. Units: arbitrary units

The change of skin elasticityWeek 0, week 4, week 8

SoftPlus was utilized to measure skin elasticity. Units: arbitrary units

The change of skin moistureWeek 0, week 4, week 8

Corneometer® CM825 was utilized to measure skin moisture. Units: arbitrary Corneometer® units 0-120

The change of skin textureWeek 0, week 4, week 8

VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units

The change of skin collagen densityWeek 0, week 4, week 8

DermaLab® Series SkinLab Combo was utilized to measure skin pores. Units: arbitrary units

Secondary Outcome Measures
NameTimeMethod
The change of skin L* valueWeek 0, week 4, week 8

Chroma Meter MM500 was utilized to measure skin L\* value. Units: arbitrary units, 0-100

The change of skin spotsWeek 0, week 4, week 8

VISIA Complexion Analysis System was utilized to measure skin spots. Units: arbitrary units

The change of skin melanin indexWeek 0, week 4, week 8

Mexameter® MX18 was utilized to measure skin melanin index. Units: arbitrary units

The change of transepidermal water loss (TEWL)Week 0, week 4, week 8

Tewameter® TM 300 was utilized to measure TEWL. Units: g/hm²

The change of skin poresWeek 0, week 4, week 8

VISIA Complexion Analysis System was utilized to measure skin pores. Units: arbitrary units

Trial Locations

Locations (1)

Chia Nan University of Pharmacy & Science

🇨🇳

Tainan, Taiwan

© Copyright 2025. All Rights Reserved by MedPath